Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P070001/S025

prodisc C SK and prodisc C Vivo

Centinel Spine, LLC · Decision date Oct 10, 2025

FDA DECISIONP070001/S025

What did the FDA approve?

FDA records P070001/S025 as a supplement to PMA P070001, with the supplement type “Panel Track”. The recorded decision is approval, dated Oct 10, 2025.

FDA approval order statement

The prodisc C SK and prodisc C Vivo are both indicated for use in skeletally mature patients for reconstruction of the disc from C3-C7 following discectomy at one or two contiguous levels for intractable radiculopathy (arm pain and/or a neurological deficit) with or without neck pain, or myelopathy due to abnormality localized to the level of the disc space and at least one of the following conditions confirmed by radiographic imaging (CT, MRI, X-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels. The prodisc C SK and prodisc C Vivo are implanted using an anterior approach. Patients should have failed at least 6 weeks of conservative treatment or demonstrated progressive signs or symptoms despite non-operative treatment prior to implantation of the prodisc C SK and prodisc C Vivo.
Regulatory pathway
PMA supplement
Supplement type
Panel Track
Clinical specialty
Orthopedic
Decision date
Oct 10, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P070001/S025
Regulatory pathway
PMA supplement
Product code
MJO
Decision code
APPR
Decision date
Oct 10, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, intervertebral disc.

Product code
MJO
FDA device class
3

For the original device and its historical approval scope, see PMA P070001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P070001 · Original PMA

    PRODISC TM-C TOTAL DISC REPLACEMENT

  2. P070001/S025 received

    Application receipt date recorded by FDA.

  3. P070001/S025 · FDA decision

    Panel Track

Timeline entries are records held by MedtechLedger for P070001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P070001

Product / regulatory recordCompanyPathwayDecision dateSource
Centinel Spine, LLCPMA approvalDec 17, 2007FDA
prodisc CP070001/S029
Centinel Spine, LLCPMA supplementJul 30, 2025FDA
prodisc CP070001/S030
Centinel Spine, LLCPMA supplementJan 15, 2026FDA
prodisc C NovaP070001/S031
Centinel Spine, LLCPMA supplementSep 9, 2026FDA

Explore the linked device profile

Other records with product code MJO

Product / regulatory recordCompanyPathwayDecision dateSource
Spineart USA, Inc.PMA supplementSep 22, 2026FDA
Synergy DiscP250028/S003
Synergy Spine Solutions, Inc.PMA supplementSep 17, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Highridge Medical, LLCPMA supplementSep 16, 2026FDA
Spineart USA, Inc.PMA supplementAug 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Centinel Spine, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
900 Airport Rd., Suite 3b, West Chester, PA, 19380

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records